- Marketwired•10 days ago
CFN Media Group , the leading creative agency and media network dedicated to legal cannabis, announces publication of an article and interview discussing GB Sciences Inc.'s holistic approach to cannabis ...
- PR Newswire•13 days agoGB Sciences Files Patent Application for the Treatment of Chronic Arthritis, Crohn's Disease, Inflammatory Bowel Disease, and Asthma; Proprietary Cannabinoid-Containing Complex Mixtures for the Treatment of Inflammatory Disorders
LAS VEGAS, Feb. 6, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced filing the second in a series of patent applications for life science inventions by its wholly-owned subsidiary, Growblox ...
- Marketwired•27 days ago
CFN Media Group , the leading creative agency and media network dedicated to legal cannabis, announces publication of an article and interview discussing recent developments and the path forward for GB ...
GBLX : Summary for GROWBLOX SCIENCES - Yahoo Finance
GrowBlox Sciences, Inc. (GBLX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.37 - 0.40|
|52 Week Range||0.15 - 0.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-3.18|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|